Progress in Mind Portugal Your Psychiatry & Neurology Resource Center COVID-19 Learn more ECNP 21 Learn more Medical education resource center Do you want to learn more? Medical education resource center The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology. Learn More THINC® Focus on cognitive symptoms in depression See More Recent News AllDepressionMigraineSchizophrenia Migraine 26 Jul, 2021 Read Time: 3 mins Congress highlights Preventive treatment gaps and priorities in migraine Speaking at #ASHAM21, Dr Stephanie Nahas, Thomas Jefferson University, identified that only a... Schizophrenia 26 Jul, 2021 Read Time: 2 mins Congress highlights Rethinking ‘persistence’ in negative symptoms for better functional recovery Even short-term persistence of negative symptoms is associated with reduced clinical and real-life... Schizophrenia 26 Jul, 2021 Read Time: 3 mins Congress highlights Can people with ultra-high risk of psychosis benefit from cognitive remediation? The FOCUS study failed to show neuro- and social-cognitive benefits of cognitive remediation in... Migraine 21 Jul, 2021 Read Time: 3 mins Congress highlights COVID-19 vaccines, migraine, and preventives: any evidence of interactions? The advent of COVID-19 vaccines has raised questions on whether vaccines impact on the management of... Schizophrenia 19 Jul, 2021 Read Time: 2 mins Congress highlights To screen or not to screen in first-episode psychosis There is no international consensus on whether or not to submit those experiencing first-episode... Mental Health 14 Jul, 2021 Read Time: 2 mins Congress highlights Perspectives on the future of psychiatry: treatment and training Prevention, prediction of outcome and precision in therapy emerged as themes at the EPA 2021... Schizophrenia 12 Jul, 2021 Read Time: 5 mins Congress highlights Intimacy, sexuality and psychosis – breaking the taboo Fact: Just likely everyone else, people with mental illness want to experience romance, love and... Depression 08 Jul, 2021 Read Time: 3 mins Congress highlights Individual vulnerability to mood and stress disorders will be predictable The dream of personalized medicine in mental health is to prevent disorders in people most at risk... Migraine 05 Jul, 2021 Read Time: 2 mins Congress highlights CGRP has a role in infection-induced pain While the role of calcitonin gene-related peptide (CGRP) in headache and migraine is well... Schizophrenia 30 Jun, 2021 Read Time: 4 mins Congress highlights Finding biotypes in psychosis – newer approaches It has been known for some time that factors such as longer duration of untreated illness are grossly... Pagination First page « Previous page ‹ … Page 7 Page 8 Current page 9 Page 10 Page 11 … Next page › Last page » Depression 18 Oct, 2014 Read Time: 3 mins Article Making the Connection: A Report from a Symposium New ways of thinking about disease states seldom come from a ‘Eureka moment’ but from the gradual... Depression 18 Oct, 2014 Read Time: 2 mins Interview Challenges treating mood disorders An interview with Dr Aideen Moran & Dr Doreen O’Rourke Pagination First page « Previous page ‹ … Page 5 Page 6 Page 7 Page 8 Current page 9 Migraine 26 Nov, 2020 Read Time: 3 mins Congress highlights Can chronic migraine be prevented by targeting risk factors? Many risk factors have been identified for predicting the transition from episodic to chronic... Migraine 25 Nov, 2020 Read Time: 3 mins Satellite symposium Migraine care in the covid-19 era: prevention is better than cure Is there a risk of further de-prioritization of migraine care in the Covid-19 era? This was one of... Migraine 13 Nov, 2020 Read Time: 3 mins Satellite symposium CGRP antibodies can help alleviate difficult-to-treat migraine Clinicians and researchers are continually expanding our understanding of disease mechanisms and... Migraine 11 Nov, 2020 Read Time: 3 mins Congress highlights If at first you don’t succeed, try another CGRP antibody for migraine prevention? If the first monoclonal antibody targeting calcitonin gene-related peptide fails to adequately... Migraine 03 Nov, 2020 Read Time: 3 mins Congress highlights Headache is an early symptom of Covid-19, often with migraine features Headache is emerging as one of the most frequent neurological symptoms of Covid-19 reported in up to... Migraine 27 Oct, 2020 Read Time: 2 mins Congress highlights What are the links between procalcitonin and micro RNA levels and migraine? Procalcitonin is a partial agonist of CGRP on the CGRP receptor, and together with CGRP appears to... Migraine 20 Oct, 2020 Read Time: 2 mins Congress highlights Why is migraine more common in women? Migraine is twice as prevalent in women than in men.1 Estrogen is a predisposing factor with... Migraine 16 Oct, 2020 Read Time: 3 mins Satellite symposium Can preventive treatment lessen the functional impact of migraine? Migraine is highly prevalent across the globe and is associated with high levels of disability and... Migraine 15 Oct, 2020 Read Time: 3 mins Congress highlights Preclinical pearls offer insights into migraine sex differences and sensory thresholds Speaking at #MTIS2020, Professor Frank Porreca, University of Arizona, USA, identified recent pearls... Migraine 14 Oct, 2020 Read Time: 3 mins Congress highlights Clinical pearls of migraine and cluster headache research uncovered From a sea of research findings, Professor Messoud Ashina, University of Copenhagen, Denmark,... Pagination First page « Previous page ‹ … Page 7 Page 8 Current page 9 Page 10 Page 11 … Next page › Last page » Schizophrenia 23 Jan, 2019 Read Time: 4 mins Article Use of fidelity scales to ensure and assess high-quality first episode psychosis services Fidelity scales ensure that services based on evidence deliver high-quality programs and outcomes,... Mental Health 17 Jan, 2019 Read Time: 3 mins Article Real-world evidence — raising organizational fluency through interactive learning techniques Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and... Depression, Schizophrenia 09 Jan, 2019 Read Time: 3 mins Article Brain imaging: focus on predicting disease course and treatment response Predicting disease course and predicting response to therapy – including the probability that a... Depression, Schizophrenia 27 Dec, 2018 Read Time: 3 mins Article ICD-11: new and fit for clinical utility and consistency The new ICD chapter on mental health and behavioral disorders is designed to offer guidelines to... Bipolar, Schizophrenia 19 Dec, 2018 Read Time: 3 mins Article Could therapeutic manipulation of critical periods of brain development benefit mental health? Many critical periods of brain development occur during infancy and childhood. When these periods are... Mental Health 17 Dec, 2018 Read Time: 3 mins Article Train, test, predict: Using big data and machine learning in psychiatry Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine clinical... Bipolar, Schizophrenia 12 Dec, 2018 Read Time: 3 mins Article Brain connectivity in early psychosis and during effective antipsychotic therapy Resting state functional MRI of the brain is providing fascinating insights into the connectivity... Bipolar, Schizophrenia 03 Dec, 2018 Read Time: 3 mins Article The OPUS Panel — Sharing lived experiences of mental illness A group of young people and their relatives (the OPUS Panel) aims to reduce societal prejudices and... Schizophrenia 28 Nov, 2018 Read Time: 4 mins Article Improving long-term outcomes in schizophrenia — translating evidence into practice The long-term goals of treatment to optimize outcomes for patients with schizophrenia are relapse... Depression, Schizophrenia 23 Nov, 2018 Read Time: 3 mins Article Making primary care count in mental health provision In countries with few resources, some recovering from conflict, mental healthcare does not generally... Pagination First page « Previous page ‹ … Page 7 Page 8 Current page 9 Page 10 Page 11 … Next page › Last page » Most Popular Depression 12 May, 2023 Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM?
